Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
| 0.0001 | |
| 0.0001 | |
| - | |
| 0.0001 | |
| 0.0001 | |
| 0.0001-0.02 | |
| 7 005 K | |
| 232 M | |
| 16 137 K | |
| -0.02 | |
| 2.553 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Continues market leadership in Colombia, Latin America's only country with universal health coverage for medical cannabis Market leader in the Colombian medical cannabis market, with Q1 2022 volume s...
Virtual Investor Conferences NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
